Literature DB >> 10606619

The arrival of HLA class II tetramers.

A J McMichael1, A Kelleher.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10606619      PMCID: PMC409890          DOI: 10.1172/JCI8943

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  16 in total

1.  Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected].

Authors:  J J Boniface; J D Rabinowitz; C Wülfing; J Hampl; Z Reich; J D Altman; R M Kantor; C Beeson; H M McConnell; M M Davis
Journal:  Immunity       Date:  1998-10       Impact factor: 31.745

2.  Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.

Authors:  F Crawford; H Kozono; J White; P Marrack; J Kappler
Journal:  Immunity       Date:  1998-06       Impact factor: 31.745

3.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D J Sourdive; A J Zajac; J D Miller; J Slansky; R Ahmed
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

4.  Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

Authors:  G S Ogg; X Jin; S Bonhoeffer; P R Dunbar; M A Nowak; S Monard; J P Segal; Y Cao; S L Rowland-Jones; V Cerundolo; A Hurley; M Markowitz; D D Ho; D F Nixon; A J McMichael
Journal:  Science       Date:  1998-03-27       Impact factor: 47.728

5.  Coordinate regulation of complex T cell populations responding to bacterial infection.

Authors:  D H Busch; I M Pilip; S Vijh; E G Pamer
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

6.  Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy.

Authors:  K Bieganowska; P Höllsberg; G J Buckle; D G Lim; T F Greten; J Schneck; J D Altman; S Jacobson; S L Ledis; B Hanchard; J Chin; O Morgan; P A Roth; D A Hafler
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

7.  Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.

Authors:  M F Callan; L Tan; N Annels; G S Ogg; J D Wilson; C A O'Callaghan; N Steven; A J McMichael; A B Rickinson
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

8.  A new look at T cells.

Authors:  A J McMichael; C A O'Callaghan
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

9.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

10.  Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

Authors:  A Gallimore; A Glithero; A Godkin; A C Tissot; A Plückthun; T Elliott; H Hengartner; R Zinkernagel
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

View more
  5 in total

1.  Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells.

Authors:  Michaela Lucas; Cheryl L Day; Jessica R Wyer; Sharon L Cunliffe; Andrew Loughry; Andrew J McMichael; Paul Klenerman
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 2.  Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets.

Authors:  S Phogat; R T Wyatt; G B Karlsson Hedestam
Journal:  J Intern Med       Date:  2007-07       Impact factor: 8.989

3.  HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.

Authors:  Thomas J Scriba; Hua-Tang Zhang; Helen L Brown; Annette Oxenius; Norbert Tamm; Sarah Fidler; Julie Fox; Jonathan N Weber; Paul Klenerman; Cheryl L Day; Michaela Lucas; Rodney E Phillips
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 4.  HLA/KIR restraint of HIV: surviving the fittest.

Authors:  Arman A Bashirova; Rasmi Thomas; Mary Carrington
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

5.  Gag- and Nef-specific CD4+ T cells recognize and inhibit SIV replication in infected macrophages early after infection.

Authors:  Jonah B Sacha; Juan P Giraldo-Vela; Matthew B Buechler; Mauricio A Martins; Nicholas J Maness; Chungwon Chung; Lyle T Wallace; Enrique J León; Thomas C Friedrich; Nancy A Wilson; Atsunobu Hiraoka; David I Watkins
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.